N-morpholin-4-ylpropanamide

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 恶嗪烷类
• 英文名称: N-morpholin-4-ylpropanamide
• 化学式: C₇H₁₄N₂O₂
• mdl: MFCD03382000
• 分子量: 158.2
• InChiKey: MZLSLWAJTLPVGV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.1
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.857
• 拓扑面积：
  41.6
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• [EN] BENZIMIDAZOLE DERIVATIVES<br/>[FR] DÉRIVÉS DE BENZIMIDAZOLE
  申请人：PFIZER

  公开号：WO2021124155A1

  公开（公告）日：2021-06-24

  The invention relates to benzimidazoles of Formula (I) and pharmaceutically acceptable salts thereof, wherein R1 to R6 are as defined in the description; to their use in medicine; to compositions containing them; to processes for their preparation; and to intermediates used in such processes. The benzimidazoles of Formula (I) are ITK inhibitors and are therefore potentially useful in the treatment of a wide range of disorders including, atopic dermatitis.

  该发明涉及式（I）的苯并咪唑及其药用盐，其中R1至R6如描述中所定义；它们在医学上的应用；含有它们的组合物；它们的制备方法；以及在这些方法中使用的中间体。式（I）的苯并咪唑是ITK抑制剂，因此在治疗包括特应性皮炎在内的广泛疾病中有潜在用途。
• [EN] PYRIDAZINYL AMINO DERIVATIVES AS ALK5 INHIBITORS<br/>[FR] DÉRIVÉS D'AMINO PYRIDAZINYLE UTILISÉS EN TANT QU'INHIBITEURS D'ALK5
  申请人：CHIESI FARM SPA

  公开号：WO2022013307A1

  公开（公告）日：2022-01-20

  The present invention relates to a compound of general formula (I) inhibiting the transforming growth factor-β (TGF-β) type I receptor (ALK5), methods of preparing such compounds, pharmaceutical compositions containing them and therapeutic use thereof. The compounds of the invention may be useful in the treatment of diseases or conditions associated with a dysregulation of ALK5 signaling pathway in a mammal.

  本发明涉及一种通式（I）的化合物，抑制转化生长因子-β（TGF-β）类型I受体（ALK5），制备这种化合物的方法，包含它们的药物组合物以及它们的治疗用途。本发明的化合物可能对哺乳动物中ALK5信号通路失调相关的疾病或病症的治疗有用。
• HYDRAZIDE COMPOUND AND THROMBOPOIETIN RECEPTOR ACTIVATOR
  申请人：Miyaji Katsuaki

  公开号：US20090253751A1

  公开（公告）日：2009-10-08

  Compounds effective for preventing, treatment or improving diseases against which activation of the thrombopoietin receptor is effective are provided. A compound represented by the formula (I) (wherein R 1 , R 2 , R 3 , L 1 , L 2 , X and Y are defined in the description), a tautomer, prodrug or pharmaceutically acceptable salt of the compound or a solvate thereof.

  提供了一种用于预防、治疗或改善激活血小板生成素受体有效对抗的疾病的化合物。该化合物由式(I)所表示（其中R1、R2、R3、L1、L2、X和Y在描述中被定义），该化合物的互变异构体、前药或药物可接受的盐或其溶剂化物。
• Polyacetal stabilizer formulation with improved color stability
  申请人：HOECHST CELANESE CORPORATION

  公开号：EP0270279A1

  公开（公告）日：1988-06-08

  An oxymethylene polymer composition which exhibits a reduced tendency to form mold deposits upon molding, reduced tendency to discolor under thermal stress and low extractable formaldehyde levels is provided by utilizing as a stabilizer a major amount of superpolyamide and a minor amount of a cyclic amidine compound of the formula: wherein R is phenyl, polynuclear aromatic, heterocyclic, cycloaliphatic and aliphatic containing at least 6 carbon atoms, as well as substituted derivatives of the listed substituents.

  本发明提供了一种氧亚甲基聚合物组合物，该组合物在成型时形成霉菌沉积物的趋势减弱，在热应力作用下褪色的趋势减弱，可萃取的甲醛含量低，其稳定剂主要是超聚酰胺和少量式如下的环状脒化合物： 其中 R 是苯基、多核芳香族、杂环族、环脂族和至少含 6 个碳原子的脂肪族，以及上述取代基的取代衍生物。
• Compositions for promoting growth of animals
  申请人：COMETEC S.r.l.

  公开号：EP0300325B1

  公开（公告）日：1993-06-16